Supplementary Figures S1-S5 from Therapeutic Targeting of <i>BRCA1</i>-Mutated Breast Cancers with Agents That Activate DNA Repair

Supplementary Figures S1-S5. SUM149PT cell line meets the screening criteria (S1); A preliminary screen identified BrdU as a small-molecule positive control (S2); Optimization of conditions for HT-screening (S3); Validation of the HT screening protocol (S4); DNA repair-activating agents exhibit minimal cytotoxicity at concentrations that enhance BER of ODD (S5).